Related Experiment Video
Updated: Aug 14, 2025
06:39
Glomerular Outgrowth as an Ex Vivo Assay to Analyze Pathways Involved in Parietal Epithelial Cell Activation
Published on: August 19, 2020
5.7K
Novel Treatment Paradigms: Focal Segmental Glomerulosclerosis
Marina de Cos1, Kristin Meliambro1, Kirk N Campbell1
1Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Kidney International Reports
|January 16, 2023
Summary
Focal segmental glomerulosclerosis (FSGS) is a kidney disease characterized by podocyte injury. Recent advances in understanding its genetic and immunologic basis offer hope for new therapeutic options.
Area of Science:
- Nephrology
- Renal Pathology
- Glomerular Diseases
Background:
- Focal segmental glomerulosclerosis (FSGS) is a kidney disease defined by specific injury patterns in glomeruli.
- Electron microscopy reveals podocyte foot process effacement and glomerular basement membrane defects in FSGS.
- Reduced podocyte number, due to various causes, underlies FSGS and leads to diverse clinical presentations.
Purpose of the Study:
- To summarize recent advancements in understanding the genetic and immunologic basis of FSGS.
- To review novel treatment paradigms and therapeutic options for FSGS.
- To highlight progress in clinical trial activity for FSGS.
Main Methods:
- Review of recent scientific literature on FSGS.
- Analysis of advances in genetic and immunologic classifications of FSGS.
- Evaluation of current clinical trial data and efficacy of repurposed agents.
Main Results:
- The classification of FSGS has been redefined based on genetic and immunologic discoveries.
- Repurposed agents show efficacy, leading to increased clinical trial activity.
- Understanding the heterogeneity of podocyte loss is crucial for varied clinical phenotypes.
Conclusions:
- Recent breakthroughs in genetics and immunology are reshaping FSGS classification.
- Emerging therapeutic strategies and clinical trials offer promising outlooks for FSGS patients.
- Further research into novel treatment paradigms is essential for improving patient outcomes.
More Related Videos
Related Concept Videos
01:24Nephrotic Syndrome I : Introduction
18
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
18
01:26Nephrotic Syndrome II : Assessment and Medical Management
16
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
16
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
481
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
481
01:28Chronic Kidney Disease III: Interprofessional Care
67
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
67
01:24Nephrotic Syndrome III : Nursing Management
26
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
26
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
215
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
215